1
|
Nikièma AS, Koala L, Unnasch TR, Diendéré J, Compaoré J, Ouédraogo MW, Kafando CM, Bakajika D, Bougouma C, Faye B, Traoré S, Dabiré RK. Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso. Parasite Epidemiol Control 2024; 25:e00352. [PMID: 38708128 PMCID: PMC11066673 DOI: 10.1016/j.parepi.2024.e00352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 03/04/2024] [Accepted: 04/21/2024] [Indexed: 05/07/2024] Open
Abstract
Skin biopsies (Skin snips) have historically been the gold standard for the diagnosis of onchocerciasis. However, in low prevalence areas and in areas with successful ivermectin mass drug administration (MDA) programs, skin snips are not sensitive enough to decide when to stop MDA; thus, serological diagnostic tools have been recommended for this purpose. This study assessed the sensitivity and specificity of the Ov16 Rapid Diagnostic Test (SD BIOLINE Onchocerciasis RDT) compared to skin snip in endemic areas undergoing ivermectin mass distribution using Community Directed Treatment with Ivermectin (CDTI) strategy. A cross-sectional study was conducted between September and November 2016 in five endemic villages in the Cascades region in Burkina Faso. Children aged 2 to 9-years were examined during the impact epidemiological survey using both the skin snip and Ov16 Rapid Diagnostic Test. The Ov16 Rapid Diagnostic Test sensitivity and specificity were determined with reference to the skin biopsy. Skin snip positivity was 1.25% in this population, while seroprevalence was 6.5%. When compared to the skin snip as the gold standard, the sensitivity of the Ov16 Rapid Diagnostic Test was 60% and the specificity 94%. When the Ov16 Rapid Diagnostic Test was considered as the gold standard, the skin snip exhibited a sensitivity of 11.5% and a specificity of 99.5%. These results are similar to other studies comparing the performance of the Ov16 ELISA to skin snips, suggesting that the Ov16 RDT may be a useful tool for ivermectin STOP MDA and post transmission surveys, assuming that the prevalence of infection is low or close to zero, and the Ov16 RDT detected also pre patent infections.
Collapse
Affiliation(s)
- Achille Sindimbasba Nikièma
- Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation (MESRI), Bobo-Dioulasso, Burkina Faso
- Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
| | - Lassane Koala
- Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation (MESRI), Bobo-Dioulasso, Burkina Faso
| | - Thomas R. Unnasch
- Center for Global Infectious Disease Research, College of Public Health, University of South Florida, Tampa, FL, USA
| | - Jeoffray Diendéré
- Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation (MESRI), Bobo-Dioulasso, Burkina Faso
| | - Justin Compaoré
- Direction de la Protection de la Santé de la Population, Programme National de Lutte Contre les Maladies Tropicales Négligées, Ministère de la Santé et de l'Hygiène Publique, Ouagadougou, Burkina Faso
| | - Mathias W. Ouédraogo
- Direction de la Protection de la Santé de la Population, Programme National de Lutte Contre les Maladies Tropicales Négligées, Ministère de la Santé et de l'Hygiène Publique, Ouagadougou, Burkina Faso
| | - Claude Montant Kafando
- Direction de la Protection de la Santé de la Population, Programme National de Lutte Contre les Maladies Tropicales Négligées, Ministère de la Santé et de l'Hygiène Publique, Ouagadougou, Burkina Faso
| | - Didier Bakajika
- Expanded Special Project for Elimination of Neglected Tropical Diseases, ESPEN, Regional Office for Africa, World Health Organization, Brazzaville, Congo
| | - Clarisse Bougouma
- Direction de la Protection de la Santé de la Population, Programme National de Lutte Contre les Maladies Tropicales Négligées, Ministère de la Santé et de l'Hygiène Publique, Ouagadougou, Burkina Faso
| | - Babacar Faye
- Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
| | - Soungalo Traoré
- Direction de la Protection de la Santé de la Population, Programme National de Lutte Contre les Maladies Tropicales Négligées, Ministère de la Santé et de l'Hygiène Publique, Ouagadougou, Burkina Faso
| | - Roch Kounbobr Dabiré
- Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest, Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation (MESRI), Bobo-Dioulasso, Burkina Faso
| |
Collapse
|
2
|
Frallonardo L, Di Gennaro F, Panico GG, Novara R, Pallara E, Cotugno S, Guido G, De Vita E, Ricciardi A, Totaro V, Camporeale M, De Iaco G, Bavaro DF, Lattanzio R, Patti G, Brindicci G, Papagni R, Pellegrino C, Santoro CR, Segala FV, Putoto G, Nicastri E, Saracino A. Onchocerciasis: Current knowledge and future goals. FRONTIERS IN TROPICAL DISEASES 2022. [DOI: 10.3389/fitd.2022.986884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Human Onchocerciasis, caused by infection by the filarial nematode Onchocerca volvulus, is a neglected public health disease that affects millions of people in the endemic regions of sub-Saharan Africa and Latin America. It is also called river blindness because the Blackflies that transmit infection breeds in rapidly flowing fresh water streams and rivers. This review features state-of-the-art data on the parasite, its endobacteria Wolbachia, the prevalence of the infection and its geographical distribution, its diagnostics, the interaction between the parasite and its host, and the pathology of Onchocerciasis. By development and optimization of the control measures, transmission by the vector has been interrupted in foci of countries in the Americas (Colombia, Ecuador, Mexico, and Guatemala)and inSudan, followed by Onchocerciasis eliminations. The current state and future perspectives for vector control and elimination strategy are described.
Collapse
|
3
|
Yengo BN, Shintouo CM, Hotterbeekx A, Yaah NE, Shey RA, Quanico J, Baggerman G, Ayong L, Vanhamme L, Njemini R, Souopgui J, Colebunders R, Ghogomu SM. Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring. Diagnostics (Basel) 2022; 12:diagnostics12061440. [PMID: 35741250 PMCID: PMC9221995 DOI: 10.3390/diagnostics12061440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Revised: 05/28/2022] [Accepted: 06/09/2022] [Indexed: 11/23/2022] Open
Abstract
Onchocerciasis is a Neglected Tropical Disease that has a significant socioeconomic impact, especially in Sub-Saharan Africa. Numerous reports indicate that the Expanded Special Project for the Elimination of Neglected Tropical Diseases needs novel diagnostic tools before achieving its goal of successful elimination of onchocerciasis in Africa. The current diagnostic tests are either invasive, insensitive, or not applicable in the field and about 25% of persons infected cannot mount immune responses against the single antigen used in the only approved Ov-16 serological test. In the quest to identify novel biomarkers that can be used to certify that a patient is free from the disease, evaluate the progress of elimination programmes, and conduct post elimination surveillances, mass spectrometric analysis of Onchocerca volvulus crude extract revealed that 1392 proteins are expressed in the adult and microfilariae stages of the parasite. Computational analysis predicted six of the proteins as O. volvulus potential diagnostic targets. Linear B-epitopes were predicted from the six proteins and used to construct a multiepitope antigen (OvMCBL02). Serological analysis revealed that the OvMCBL02 test significantly differentiated between serum samples of onchocerciasis patients from the Kombone Health Area in the South West Region of Cameroon (n = 63) and control serum samples from Rwanda (n = 29) and Europe (n = 26) as well as between serum samples from the onchocerciasis hyperendemic region of Kombone Health Area (n = 63) and the hypoendemic region of Bandjoun Health District (n = 54). Interestingly, the test did not cross-react with serum samples from patients suffering from related nematode infections, thereby suggesting that further characterization of the OvMCBL02 multiepitope antigen will render it an additional member of the diagnostic toolbox for the elimination of onchocerciasis.
Collapse
Affiliation(s)
- Bernis Neneyoh Yengo
- Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon; (B.N.Y.); (C.M.S.); (N.E.Y.); (R.A.S.)
| | - Cabirou Mounchili Shintouo
- Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon; (B.N.Y.); (C.M.S.); (N.E.Y.); (R.A.S.)
- Department of Gerontology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium;
- Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
| | - An Hotterbeekx
- Global Health Institute, University of Antwerp, 2610 Antwerp, Belgium; (A.H.); (R.C.)
- Molecular Pathology Group, Laboratory of Cell biology and Histology, University of Antwerp, 2610 Antwerp, Belgium
| | - Ntang Emmaculate Yaah
- Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon; (B.N.Y.); (C.M.S.); (N.E.Y.); (R.A.S.)
| | - Robert Adamu Shey
- Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon; (B.N.Y.); (C.M.S.); (N.E.Y.); (R.A.S.)
| | - Jusal Quanico
- Center for Proteomics, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerpen, Belgium; (J.Q.); (G.B.)
| | - Geert Baggerman
- Center for Proteomics, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerpen, Belgium; (J.Q.); (G.B.)
| | - Lawrence Ayong
- Malaria Research Unit, Centre Pasteur Cameroon, Yaoundé P.O. Box 1274, Cameroon;
| | - Luc Vanhamme
- Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Gosselies Campus, Université Libre de Bruxelles, 1070 Brussels, Belgium; (L.V.); (J.S.)
| | - Rose Njemini
- Department of Gerontology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium;
- Frailty in Ageing Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
| | - Jacob Souopgui
- Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Gosselies Campus, Université Libre de Bruxelles, 1070 Brussels, Belgium; (L.V.); (J.S.)
| | - Robert Colebunders
- Global Health Institute, University of Antwerp, 2610 Antwerp, Belgium; (A.H.); (R.C.)
| | - Stephen Mbigha Ghogomu
- Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea P.O. Box 63, Cameroon; (B.N.Y.); (C.M.S.); (N.E.Y.); (R.A.S.)
- Correspondence: ; Tel.: +237-6-7845-5646
| |
Collapse
|